✦ LIBER ✦

Treatment Strategies and Issues in Low/Intermediate-1–Risk Myelodysplastic Syndrome (MDS) Patients

✍ Scribed by David T. Bowen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Current treatment strategies in low-risk

✍ Aristoteles A.N. Giagounidis; Ulrich Germing; Carlo Aul 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Response Assessments in Low-Risk and Hig

✍ Pierre Fenaux 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Darbepoetin alpha for the treatment of a

✍ Pellegrino Musto; Francesco Lanza; Enrico Balleari; Alberto Grossi; Antonietta F 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

P-320 ARCADE (20090160): A randomized co

✍ Gasai, E.; Pan, C.; Tankersley, C. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Phase 1 dose-ranging study of ezatiostat

✍ Azra Raza, Naomi Galili, Deborah Mulford, Scott E Smith, Gail L Brown, David P S 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 203 KB

Neutropenia at baseline could indicate p

✍ Massimo Breccia; Giuseppina Loglisci; Adriano Salaroli; Paola Finsinger; Alessan 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 107 KB